{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:19:54Z","timestamp":1791296394310,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40620-018-0482-6","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T07:04:07Z","timestamp":1519887847000},"page":"731-741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Defective activation of the MAPK\/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Sch\u00f6nlein purpura"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-5737","authenticated-orcid":false,"given":"Annamaria","family":"Milillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8860-7987","authenticated-orcid":false,"given":"Clelia","family":"Molinario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Costanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5829-4396","authenticated-orcid":false,"given":"Gisella","family":"Vischini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-9307","authenticated-orcid":false,"given":"Francesca","family":"La Carpia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"La Greca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-7779","authenticated-orcid":false,"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-2370","authenticated-orcid":false,"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-5972","authenticated-orcid":false,"given":"Fiorella","family":"Gurrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9079-9175","authenticated-orcid":false,"given":"Eugenio","family":"Sangiorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738\u2013748. https:\/\/doi.org\/10.1056\/NEJMra020109","journal-title":"N Engl J Med"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40620-015-0248-3","volume":"29","author":"C Pozzi","year":"2016","unstructured":"Pozzi C (2016) Treatment of IgA nephropathy. J Nephrol 29:21\u201325. https:\/\/doi.org\/10.1007\/s40620-015-0248-3","journal-title":"J Nephrol"},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40620-015-0257-2","volume":"29","author":"C Pozzi","year":"2016","unstructured":"Pozzi C, Sarcina C, Ferrario F (2016) Treatment of IgA nephropathy with renal insufficiency. J Nephrol 29:551\u2013558. https:\/\/doi.org\/10.1007\/s40620-015-0257-2","journal-title":"J Nephrol"},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1053\/j.ajkd.2011.05.033","volume":"58","author":"J Floege","year":"2011","unstructured":"Floege J (2011) The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis 58:992\u20131004","journal-title":"Am J Kidney Dis"},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/ASN.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22:1795\u20131803","journal-title":"J Am Soc Nephrol"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40620-014-0118-4","volume":"28","author":"Y Hiki","year":"2015","unstructured":"Hiki Y, Hori H, Yamamoto K et al (2015) Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region. J Nephrol 28:181\u2013186. https:\/\/doi.org\/10.1007\/s40620-014-0118-4","journal-title":"J Nephrol"},{"issue":"Suppl 1","key":"482_CR7","first-page":"59","volume":"13","author":"Y Nakagawa","year":"1999","unstructured":"Nakagawa Y, Saito K, Nishi S et al (1999) Recurrence of IgA nephropathy 17\u00a0months after renal transplantation in the allograft transmitted thin basement membrane disease (TBMD) from donor. Clin Transpl 13(Suppl 1):59\u201362","journal-title":"Clin Transpl"},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00007890-198204000-00006","volume":"33","author":"F Sanfilippo","year":"1982","unstructured":"Sanfilippo F, Croker BP, Bollinger RR (1982) Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 33:370\u2013376","journal-title":"Transplantation"},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2169\/internalmedicine.45.1837","volume":"45","author":"Y Iwata","year":"2006","unstructured":"Iwata Y, Wada T, Uchiyama A et al (2006) Remission of IgA nephropathy after allogeneic peripheral blood stem cell transplantation followed by immunosuppression for acute lymphocytic leukemia. Intern Med 45:1291\u20131295","journal-title":"Intern Med"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"639074","DOI":"10.1155\/2011\/639074","volume":"2011","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Suzuki H, Nakata J et al (2011) Pathological role of tonsillar B cells in IgA nephropathy. Clin Dev Immunol 2011:639074","journal-title":"Clin Dev Immunol"},{"key":"482_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2015.52","author":"A Milillo","year":"2015","unstructured":"Milillo A, La Carpia F, Costanzi S et al (2015) A SPRY2 mutation leading to MAPK\/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/ejhg.2015.52","journal-title":"Eur J Hum Genet"},{"key":"482_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2215\/CJN.06710810","volume":"6","author":"JC Davin","year":"2011","unstructured":"Davin JC (2011) Henoch-Sch\u00f6nlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679\u2013689","journal-title":"Clin J Am Soc Nephrol"},{"key":"482_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0457-z","author":"K Xu","year":"2017","unstructured":"Xu K, Zhang L, Ding J et al (2017) Value of the Oxford classification of IgA nephropathy in children with Henoch-Sch\u00f6nlein purpura nephritis. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-017-0457-z","journal-title":"J Nephrol"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.4049\/jimmunol.179.8.5553","volume":"179","author":"G Gorelik","year":"2007","unstructured":"Gorelik G, Fang JY, Wu A et al (2007) Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 179:5553\u20135563","journal-title":"J Immunol"},{"key":"482_CR15","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1016\/S0021-9258(17)37320-9","volume":"269","author":"A Tordai","year":"1994","unstructured":"Tordai A, Franklin RA, Patel H et al (1994) Cross-linking of surface IgM stimulates the Ras\/Raf-1\/MEK\/MAPK cascade in human B lymphocytes. J Biol Chem 269:7538\u20137543","journal-title":"J Biol Chem"},{"key":"482_CR16","doi-asserted-by":"publisher","first-page":"e89646","DOI":"10.1371\/journal.pone.0089646","volume":"9","author":"AA Akhiani","year":"2014","unstructured":"Akhiani AA, Werlenius O, Aurelius J et al (2014) Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes. PLoS One 9:e89646","journal-title":"PLoS One"},{"key":"482_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm715","volume":"3","author":"CA Hazzalin","year":"2002","unstructured":"Hazzalin CA, Mahadevan LC (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 3:30\u201340. https:\/\/doi.org\/10.1038\/nrm715","journal-title":"Nat Rev Mol Cell Biol"},{"key":"482_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2567.2008.02921.x","volume":"127","author":"HE Ambrose","year":"2009","unstructured":"Ambrose HE, Willimott S, Beswick RW et al (2009) Poly(ADP-ribose) polymerase-1 (Parp-1)-deficient mice demonstrate abnormal antibody responses. Immunology 127:178\u2013186. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02921.x","journal-title":"Immunology"},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/art.10833","volume":"48","author":"C Deng","year":"2003","unstructured":"Deng C, Lu Q, Zhang Z et al (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthr Rheum 48:746\u2013756","journal-title":"Arthr Rheum"},{"key":"482_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.onc.1208005","volume":"24","author":"A Reale","year":"2005","unstructured":"Reale A, Matteis G, De Galleazzi G et al (2005) Modulation of DNMT1 activity by ADP-ribose polymers. Oncogene 24:13\u201319. https:\/\/doi.org\/10.1038\/sj.onc.1208005","journal-title":"Oncogene"},{"key":"482_CR21","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.1073\/pnas.0508606103","volume":"103","author":"TM Kauppinen","year":"2006","unstructured":"Kauppinen TM, Chan WY, Suh SW et al (2006) Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1\/2. Proc Natl Acad Sci 103:7136\u20137141. https:\/\/doi.org\/10.1073\/pnas.0508606103","journal-title":"Proc Natl Acad Sci"},{"key":"482_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2567.2011.03524.x","volume":"135","author":"T Seidl","year":"2012","unstructured":"Seidl T, Whittall T, Babaahmady K, Lehner T (2012) B-cell agonists up-regulate AID and APOBEC3G deaminases, which induce IgA and IgG class antibodies and anti-viral function. Immunology 135:207\u2013215. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03524.x","journal-title":"Immunology"},{"key":"482_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1084\/jem.190.3.323","volume":"190","author":"CE Schrader","year":"1999","unstructured":"Schrader CE, Edelmann W, Kucherlapati R, Stavnezer J (1999) Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J Exp Med 190:323\u2013330","journal-title":"J Exp Med"},{"key":"482_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaut.2013.01.005","volume":"41","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhao M, Sawalha AH et al (2013) Impaired DNA methylation and its mechanisms in CD4+ T cells of systemic lupus erythematosus. J Autoimmun 41:92\u201399. https:\/\/doi.org\/10.1016\/j.jaut.2013.01.005","journal-title":"J Autoimmun"},{"key":"482_CR25","doi-asserted-by":"publisher","first-page":"37497","DOI":"10.1074\/jbc.M211739200","volume":"278","author":"HS Kim","year":"2003","unstructured":"Kim HS, Song M-C, Kwak IH et al (2003) Constitutive induction of p-Erk1\/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence. J Biol Chem 278:37497\u201337510. https:\/\/doi.org\/10.1074\/jbc.M211739200","journal-title":"J Biol Chem"},{"key":"482_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0090-1229(92)90201-X","volume":"64","author":"SM Smith","year":"1992","unstructured":"Smith SM, Tokuda S, Tsukamoto H (1992) Mucosal immune dysfunction associated with alcoholic IgA nephropathy. Clin Immunol Immunopathol 64:205\u2013209","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0482-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0482-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0482-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:40Z","timestamp":1777564660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/31\/5\/731\/8371451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0482-6","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was authorized by the Comitato di Bioetica of the Catholic University (#27321\/13).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Informed consent was obtained from all participants to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}